HANS WAGENAAR: Open Payments
NPI 1811955073 · SIOUX FALLS, SD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$629 in 27 payments from 13 companies in 2025. Trend: 2023 $163 · 2024 $163 · 2025 $629
Food & beverage: $629
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $145 |
| Sumitomo Pharma America, Inc. | 5 | $96 |
| IMMUNITYBIO, INC. | 3 | $57 |
| HISTOSONICS, INC. | 1 | $52 |
| Antares Pharma, Inc. | 3 | $51 |
| Teleflex LLC | 2 | $46 |
| C. R. Bard, Inc. & Subsidiaries | 2 | $42 |
| UROGEN PHARMA, INC. | 2 | $37 |
| Boston Scientific Corporation | 1 | $24 |
| Novartis Pharmaceuticals Corporation | 1 | $23 |
Products named: RYBREVANT, GEMTESA, ANKTIVA, XYOSTED, ERLEADA, ZUSDURI, ORGOVYX, LithoVue Elite.
Industry payments across SD — which companies pay providers there.
